HPVC2019-159: Biopharmaceuticals Long-Acting Granulocyte-Colony Stimulating Factor
Current Contract
Contract start date: 28 Jun 2019
Contract end date: 27 Jun 2025
Option periods: Nil
Description
Contract for the provision of long acting granulocyte colony-stimulating factor (G-CSF) to Victorian public hospitals and health services.Additional information
Contract Details
The Principal Period (2 years) commenced on 28 June 2019 until 27 June 2021.
The first Contract Option period of two years has been executed - effective from 28 June 2021 until 27 June 2023.
The second Contract Option period of two years has been executed – effective from 28 June 2023 until 27 June 2025.
Option Periods Remaining
Nil.
Categories
Category 1: Biopharmaceuticals Long-Acting Granulocyte Colony-Stimulating Factor
Update: 4 November 2024
- HSV has proposed to current supplier to extend the current contract from 28 June 2025 to 29 January 2026.
- Responses to extension need to directed through the HSV Procurement Portal between Thursday 7 November to Thursday 21 November.
Important Note:
- Please ensure that that you are registered to access the Procurement Portal and you’re your details are up to date. More information can be found on the HSV website,
or you can contact:
HSV Helpdesk
Phone: (03) 9947 3900
Email: helpdesk@healthsharevic.org.au
Tentative dates
Announcement of outcome to suppliers: 20 December 2024.
Announcement of outcome to health services: 20 January 2025.
Contract Commencement Date: 28 June 2025